Assignee profile:

Oramed Ltd.

City:

Jerusalem

Country:

Israel

Published Applications:

18

Last publication date:

2024-10-31

Patent Grants:

10

Last grant date:

2023-05-30

Top Inventors for applications by Oramed Ltd.

These are the the leading inventors for applications assigned to Oramed Ltd.:

Recent patent applications by Oramed Ltd.

Oramed Ltd. based in Jerusalem, IL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-10-31
US20240358647A1
Human necessities

Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same

#2 | 2024-06-06
US20240181018A1
Human necessities

Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof

#3 | 2023-07-06
US20230210956A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING DIABETES

#4 | 2022-01-06
US20220000986A1
Human necessities

Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof

#5 | 2021-12-02
US20210369626A1
Human necessities

Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same

#6 | 2021-04-22 ✅ Patent 11,660,327 granted on 2023-05-30
US20210113663A1
Human necessities

Methods and compositions for oral administration of proteins

#7 | 2021-03-18 ✅ Patent 11,395,848 granted on 2022-07-26
US20210077588A1
Human necessities

Methods and compositions for treating diabetes

#8 | 2019-12-12
US20190374615A1
Human necessities

Methods and Compositions for Treating Diabetes

#9 | 2019-10-24 ✅ Patent 10,933,022 granted on 2021-03-02
US20190321303A1
Human necessities

Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same

#10 | 2019-10-17
US20190314275A1
Human necessities

Methods and Compositions for Rectal Administration of Exenatide

#11 | 2019-07-11 ✅ Patent 10,967,051 granted on 2021-04-06
US20190209655A1
Human necessities

Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof

#12 | 2018-12-27 ✅ Patent 10,881,714 granted on 2021-01-05
US20180369339A1
Human necessities

Methods and compositions for oral administration of proteins

#13 | 2015-01-15 ✅ Patent 10,398,762 granted on 2019-09-03
US20150017238A1
Human necessities

Methods and compositions for treating diabetes

#14 | 2014-12-25 ✅ Patent 10,342,764 granted on 2019-07-09
US20140377344A1
Human necessities

Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same

#15 | 2013-08-01 ✅ Patent 10,350,162 granted on 2019-07-16
US20130195939A1
Human necessities

Methods and compositions for oral administration of exenatide

#16 | 2011-06-16 ✅ Patent 9,186,412 granted on 2015-11-17
US20110142800A1
Human necessities

Methods and compositions for oral administration of insulin

#17 | 2011-02-24
US20110046053A1
Human necessities

METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF EXENATIDE

#18 | 2011-01-20 ✅ Patent 10,058,593 granted on 2018-08-28
US20110014247A1
Human necessities

Methods and compositions for oral administration of proteins

Also check out ORAMED LTD.'s (Jerusalem, Israel) applicant profile with 11 patent applications submitted.

AssigneeID:

32643 ⎘